Back to Results
First PageMeta Content
Ophthalmology / Macular degeneration / Vascular endothelial growth factor / Ranibizumab / Advanced Micro Devices / Bevacizumab / Age-Related Eye Disease Study / Drusen / Prevalence / Medicine / Health / Vision


Document Date: 2015-03-26 18:45:54


Open Document

File Size: 872,70 KB

Share Result on Facebook

City

Auckland / London / Wellington / /

Company

Age-Related Eye Disease Study Research Group / Thomson / NEW ZEALAND MEDICAL JOURNAL / AMD / Statistics New Zealand / /

Country

New Zealand / United States / /

Currency

AMD / USD / /

/

Facility

University of Auckland / Hamilton Eye Clinic / /

IndustryTerm

year age / health services / age / macular degeneration healthcare / healthcare / fish products / ophthalmic healthcare services / transportation difficulties / ophthalmic services / healthcare services / healthcare planners / /

MedicalCondition

scar / incident age-related macular degeneration / macular degeneration / severe stroke / early disease / systemic hypertension / obesity / late disease / age-related macular degeneration / illness / CD eds Age-related macular degeneration / blindness / age-related eye disease / disease / severe cardiac angina / cardiac angina / neovascular age-related macular degeneration / less expensive blindness / AMD disease / depression / cataract / /

MedicalTreatment

cataract surgery / /

Organization

World Health Organization / Department of Statistics / OECD / Organization for Economic Cooperation and Development / U.S. Medicare / Blind Foundation / University of Auckland / /

Person

Van Leeuwen / Alistair Scott / Andrew Worsley / David Worsley / Arch Ophthalmol / /

Position

Statistician / Author / Professor / major driver / Lieske HB / et al / /

Product

VEGF / /

ProvinceOrState

Georgia / /

URL

http /

SocialTag